Background/aim: To investigate the utility of preoperative serum cancer antigen 125 (CA 125) levels in type 1 endometrial carcinoma (EC) as a marker for determining poor prognostic factors and survival. Material and methods: All patients with endometrial cancer, who had been treated between 2012 and 2020, were retrospectively reviewed, and finally, 256 patients with type 1 endometrium carcinoma were included in the study. The relationship between the clinicopathological characteristics, CA 125 level, and survival rates were analyzed. The cut-off value for the preoperative serum CA 125 level was defined as 16 IU/L. Results: The median serum CA 125 levels were significantly higher in patients with deep myometrial invasion, lymph node metastasis, lymphovascular space invasion, cervical stromal and adnexal involvement, advanced stage, positive peritoneal cytology, recurrence, and adjuvant therapy requirement. Serum CA 125 cut-off values determined according to clinicopathologic factors ranged from 15.3 to 22.9 IU/L (sensitivity 61%-77%, specificity 52%-73%). The disease-specific survival rate was significantly higher in patients with CA 125 levels < 16 IU/L (P = 0.047). Conclusion: The data showed that choosing a lower threshold value for the CA 125 level (16 IU/L) instead of 35 IU/L, could be more useful in type 1 EC patients with negative prognostic factors.
Cancer antigen 125 (CA 125), cut-off value, endometrial carcinoma, prognosis, survival
BARAN, ŞAFAK YILMAZ; ALEMDAROĞLU, SONGÜL; DURDAĞ, GÜLŞEN DOĞAN; ŞİMŞEK, SEDA YÜKSEL; BOLAT, FİLİZ; KÖSE, FATİH; and ÇELİK, HÜSNÜ
"What is the predictive value of preoperative CA 125 level on the survival rate of type 1endometrial cancer?,"
Turkish Journal of Medical Sciences: Vol. 51:
1, Article 40.
Available at: https://journals.tubitak.gov.tr/medical/vol51/iss1/40